Skip to content
Find Clinical Trials
Find Clinical Trials
Home » Find Clinical Trials » The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopausal women and men. A prospective, international phase III study with a 6-month double-blind period to assess the efficacy and safety of a daily oral administration of S06911 versus S12911 (strontium ranelate 2g) and a 6-month open-labelled extension for a subgroup of patients to assess safety of a daily oral administration of S06911.

The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopausal women and men. A prospective, international phase III study with a 6-month double-blind period to assess the efficacy and safety of a daily oral administration of S06911 versus S12911 (strontium ranelate 2g) and a 6-month open-labelled extension for a subgroup of patients to assess safety of a daily oral administration of S06911.

Share Print
Servier Protocol Code: CL3-06911-002 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2009-013935-39

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00
Results
English (USA)
Interventions / Treatments
  • Osteoporosis
  • S006911
  • STRONTIUM RANELATE
  • VITAMINE D
Other study id numbers
  • CL3-06911-002